INFAI

York, United Kingdom Founded: 1989 • Age: 37 yrs
Develops non-invasive medical diagnostic tests for various diseases and conducts clinical studies.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 5 Services tracked
Competitors - Brand Intelligence

About INFAI

INFAI is a company based in York (United Kingdom) founded in 1989. It operates as a B2B. INFAI offers products and services including Helicobacter Test INFAI, Metabo Test INFAI, Cardio Test INFAI, Gastromotal, and Pancreo Lip.

  • Headquarter York, United Kingdom
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Infai Gmbh
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of INFAI

INFAI offers a comprehensive portfolio of products and services, including Helicobacter Test INFAI, Metabo Test INFAI, Cardio Test INFAI, Gastromotal, and Pancreo Lip.

Product name locked
Category locked
Primary

Non-invasive detection of Helicobacter pylori bacterium in patients.

Product name locked
Category locked
Locked

Screens for metabolic diseases in newborns using NMR spectroscopy.

Product name locked
Category locked
Locked

Assesses cardiovascular disease risk through serum analysis.

Product name locked
Category locked
Locked

Evaluates gastrointestinal conditions with stable isotope methods.

Product name locked
Category locked
Locked

Analyzes pancreatic function for related disorders.

Funding Insights of INFAI

Premium access

Detailed funding history for INFAI

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by INFAI

Investments
Premium access

Investment portfolio details for INFAI

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - INFAI

Premium access

Detailed financials for INFAI

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Infai Comparisons

INFAI Primary company
Description
Develops non-invasive medical diagnostic tests for various d...
Location
York, United Kingdom
Founded Year
1989
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for INFAI

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of INFAI

Premium access

Detailed competitors of INFAI

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Infai

Premium access

Complete news archive for INFAI

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about INFAI

INFAI was founded in 1989.

INFAI is headquartered in York, United Kingdom.

INFAI specializes in innovative diagnostic products for healthcare, using stable isotopes and NMR spectroscopy to detect gastrointestinal, metabolic, and cardiovascular conditions. The company offers non-invasive breath tests and metabolite screening services, collaborating with pharmaceutical firms for clinical studies. Headquartered in Germany with offices in the UK and Europe, INFAI focuses on research and development to reduce healthcare costs through accurate, efficient diagnostics.

INFAI offers Helicobacter Test INFAI, Metabo Test INFAI, Cardio Test INFAI, Gastromotal, and Pancreo Lip.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available